Since the synthesis of its first morphine glucuronides in 1993, Lipomed has become a leading producer and supplier of high quality Drugs of Abuse Reference Standards. Lipomed currently provides more than 190 different native and/or deuterated reference substances intended for forensic analysis, toxicology, pharmaceutical development, drug disposition research and many other applications.
With the regular appearance of new designer drugs (e.g. 2C-I) and/or drugs diverted from their therapeutic application (e.g. Tramadol), the need for high quality and reliable reference standards is increasing. To meet this demand, Lipomed's Research and Development department has established a continuous development program for the synthesis of new reference substances.
For information go to http://lipomed.com/diagnostics/?i18n=f8b20f1164a7b4ee7184c187fb40fdca
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment